Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMF-001 Phase 1 Study With Refractory Esophageal Tumor

NCT01003808 is registered in ClinicalTrials.gov with ImmunoFrontier, Inc. as lead sponsor.

NCT NCT01003808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01003808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMF-001 Phase 1 Study With Refractory Esophageal Tumor
Lead sponsor
ImmunoFrontier, Inc.
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2009
Completion date
December 31, 2012
Enrollment
25 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer